A larger view of genetic regulation
Genome-wide association studies, or GWAS, have become a mainstay of research into complex traits and disease. They can identify stretches of the genome associated with conditions ranging from breast cancer to heart disease and diabetes. But finding an associated stretch of DNA is not the same as identifying the gene, mechanism or biological pathway behind that association.
That gap matters because many GWAS signals lie in regions that regulate gene activity rather than in the genes themselves. Researchers therefore need to understand how inherited variants affect both gene expression and splicing—the process by which cells assemble RNA instructions into different forms. Those links can help turn a statistical association into a more concrete explanation of biology, and eventually point researchers toward possible drug targets.
A study published in Science argues that the apparent limits of earlier work may have reflected the size of the underlying datasets. Using a TOPMed expression and splicing quantitative trait locus dataset, researchers report that increasing sample size can reveal a second, third and even fourth genetic signal affecting the same gene.
Why the number of samples changes the picture
Each person carries one of three possible genotypes at a given inherited variant, reflecting the alleles received from their parents. Those genotypes can be associated with lower, intermediate or higher levels of gene expression. Mapping those relationships is the purpose of expression quantitative trait locus, or eQTL, analysis. Closely related splicing quantitative trait locus, or sQTL, analysis looks for variants associated with changes in RNA splicing.
Earlier efforts frequently relied on data from the Genotype-Tissue Expression project, known as GTEx, to connect GWAS findings with eQTLs and sQTLs. Those studies quickly appeared to reach a ceiling in the number of regulatory sites detectable for an individual gene. The new work suggests that ceiling was not necessarily biological. With more data, additional independent effects can become visible.
That is an important distinction. If researchers can observe only the strongest regulatory association near a gene, they may miss other variants that also influence its activity. A larger dataset can separate effects that would otherwise blur together, producing a more detailed map of how inherited variation shapes the cellular machinery.
From association signals to mechanisms
The study’s premise is not that every GWAS hit immediately becomes a therapeutic target. Instead, it provides a route for interpreting what those hits may mean. A genetic variant associated with disease risk may sit in a regulatory region. By linking that variant to changes in expression or splicing, researchers can narrow the set of genes and processes worth investigating.
Gene regulation is also networked. As University of Michigan researcher Laura Scott explained, changing expression of one part of a biological system—such as a regulator involved in a cellular stress response—can affect expression levels in other parts of that same system. That means a variant’s influence may be broader than a one-gene, one-trait model implies.
For disease research, this reinforces the value of combining large genomic datasets with functional analyses. A GWAS can identify where an association lies. eQTL and sQTL studies can help identify which gene activities track with that inherited variation. Together, they offer a more grounded way to move from population-level patterns toward hypotheses that can be tested in cells, tissues and eventually clinical research.
A data-scale lesson for genomics
The result is also a reminder that negative or limited findings in genomics may be constrained by statistical power. A study may not detect several regulatory effects around a gene because they do not exist, but because available data are insufficient to distinguish them. Expanding the dataset can change that conclusion.
The researchers’ findings do not eliminate the challenge of interpreting complex traits. Expression and splicing are only parts of the biological chain between inherited variation and a person’s observable characteristics. Still, identifying multiple regulatory switches for a gene adds resolution where previous maps were comparatively coarse.
As datasets grow, the practical task will be to decide which of the newly visible signals are most relevant to a particular disease or trait, in which tissues they matter and how they interact with other regulatory effects. The study makes the case that looking for a single decisive switch may be too simple. For many genes, the regulatory architecture may be made up of several independently detectable controls—and seeing them requires substantially more data.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
